Aster Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
Aster Capital Management's CRVS Position: Q3 2026 in Review
Aster Capital Management opened a new position in Corvus Pharmaceuticals (CRVS) in Q3 2026: 460 shares worth $5.3K. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings.
177 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.
- Aster Capital Management held 460 shares of Corvus Pharmaceuticals worth $5.3K as of Q3 2026.
- Corvus Pharmaceuticals was a new Aster Capital Management position in Q3 2026.
- Corvus Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #833 holding.
- 177 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.